Amyotrophic Lateral Sclerosis
FY23 Therapeutic Idea Award - Biomarker Option
The list of Fiscal Year 2023 Amyotrophic Lateral Sclerosis Research Program Therapeutic Idea Award - Biomarker Option applications recommended for funding is for informational purposes only. Identification on the list of applications recommended for funding is not intended to either confer a right to funding nor does it guarantee funding. The award of federal funds to support any of these applications is contingent upon successful negotiations and applicable federal policy.
Institution | Principal Investigator |
---|---|
Columbia University Medical Center | Wassim Elyaman |
FORMATION VENTURE ENGINEERING FOUNDRY INC | Ajay Verma |
Macquarie University | Albert Lee |
Tardigrade Therapeutics | Steven Perrin |
Universita degli Studi di Pavia | Marco Peviani |
Last updated Friday, December 1, 2023